Pleasanton, CA, United States of America

Mark Yamanaka

USPTO Granted Patents = 15 (Patent Applications = 8)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 7.4

ph-index = 7

Forward Citations = 87(Granted Patents)

Company Filing History:

11 out of 1,624

E. R. Squibb Sons, Inc.

patents

2 out of 3,681

Bristol-myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2011-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11530267 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2022-12-20),

2. 11512130 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2022-11-29),

3. 11236165 - Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof (2022-02-01),

4. 11236164 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2022-02-01),

5. 11236163 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2022-02-01),

6. 11001630 - Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof (2021-05-11),

7. 10988536 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2021-04-27),

8. 10988535 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2021-04-27),

9. 10344089 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof (2019-07-09),

10. 9499632 - Human antibodies that bind CD22 and uses thereof (2016-11-22),

11. 9217033 - Monoclonal antibodies against Glypican-3 (2015-12-22),

12. 8680247 - Monoclonal antibodies against glypican-3 (2014-03-25),

13. 8481683 - Human antibodies that bind CD22 and uses thereof (2013-07-09),

14. 8399647 - Alpha5-beta1 antibodies and their uses (2013-03-19),

15. 8039596 - Alpha 5-beta 1 antibodies and their uses (2011-10-18),

Title: The Inventor Mark Yamanaka: Pioneering Innovations in Pleasanton

Introduction: Mark Yamanaka is a visionary inventor based in Pleasanton, California, known for his groundbreaking contributions to various industries.

Latest Patents: Mark Yamanaka holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Mark Yamanaka has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Mark Yamanaka has collaborated with top researchers, engineers, and scientists to bring his ideas to life, leading to successful partnerships and game-changing inventions.

Conclusion: Mark Yamanaka's passion for innovation and his relentless drive to push boundaries continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.